Prognosis of oral pre-malignant lesions: Significance of clinical, histopathological, and molecular biological characteristics

Critical Reviews in Oral Biology and Medicine

Volumn 14, Issue 1, 2003, Pages 47-62

  Reibel, Jesper ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Epithelial dysplasia; Leukoplakia; Markers; Oral pre cancer; Prognosis

Indexed keywords

TUMOR MARKER;

CELL TRANSFORMATION; DIFFERENTIAL DIAGNOSIS; EPITHELIUM; GENETIC MARKER; GENETICS; HUMAN; LEUKOPLAKIA; MOUTH TUMOR; NOMENCLATURE; PATHOLOGY; PRECANCER; PROGNOSIS; REVIEW; SMOKING; THRUSH;

CANDIDIASIS, ORAL; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSIS, DIFFERENTIAL; EPITHELIUM; GENETIC MARKERS; HUMANS; LEUKOPLAKIA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; PROGNOSIS; SMOKING; TERMINOLOGY; TUMOR MARKERS, BIOLOGICAL;

EID: 0037672807     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/154411130301400105     Document Type: Review

References (198)

1. Abbey LM, Kaugars GE, Gunsolley JC, Burns JC, Page DG, Svirsky JA, et al. (1995). Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80:188-191.
2. Abbey LM, Kaugars GE, Gunsolley JC, Burns JC, Page DG, Svirsky JA, et al. (1998). The effect of clinical information on the histopathologic diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:74-77.
3. Allen CM (1997). Evidence-based medicine and the clinical practice of oral and maxillofacial pathology (editorial). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:227.
4. Axéll T (1993). Oral mucosal changes related to smokeless tobacco usage: research findings in Scandinavia. Oral Oncol Eur J Cancer 29(B):299-302.
5. Axéll T, Holmstrup P, Kramer IRH, Pindborg JJ, Shear M (1984). International seminar on oral leukoplakia and associated lesions related to tobacco habits. Community Dent Oral Epidemiol 12:145-154.
6. Axéll T, Pindborg JJ, Smith CJ, van der Waal I (1996). Oral white lesions with special reference to precancerous and tobaccorelated lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 25:49-54.
7. Bánóczy J (1977). Follow-up studies in oral leukoplakia. J Maxillofac Surg 5:69-75.
8. Bánóczy J, Csiba A (1976). Occurrence of epithelial dysplasia in oral leukoplakia. Analysis and follow-up study of 12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 42:766-774.
9. Bánóczy J, Sugar L (1972). Longitudinal studies in oral leukoplakias. J Oral Pathol 1:265-272.
10. Bánóczy J, Gintner Z, Dombi C (2001). Tobacco use and oral leukoplakia. J Dent Educ 65:322-327.
11. Baric JM, Alman JE, Feldman RS, Chauncey HH (1982). Influence of cigarette, pipe, and cigar smoking, removable partial dentures, and age on oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 54:424-429.
12. Barrett AW, Kingsmill VJ, Speight PM (1998). The frequency of fungal infection in biopsies of oral mucosal lesions. Oral Dis 4:26-31.
13. Bloor BK, Seddon SV, Morgan PR (2001). Gene expression of differentiation-specific keratins in oral epithelial dysplasia and squamous cell carcinoma. Oral Oncol 37:251-261.
14. Bosch FX, Ouhayoun JP, Bader BL, Collin C, Grund C, Lee I, et al. (1989). Extensive changes in cytokeratin expression patterns in pathologically affected human gingiva. Virchows Arch B Cell Pathol Incl Mol Pathol 58:59-77.
15. Bouquot JE, Weiland LH, Kurland LT (1988). Leukoplakia and carcinoma in situ synchronously associated with invasive oral/oropharyngeal carcinoma in Rochester, Minn., 1935-1984. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 65:199-207.
16. Boysen M, Lovdal O, Tausjo J, Winther F (1992). The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 28:426-430.
17. Braakhuis BJM, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH (2002). Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 24:198-206.
18. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, et al. (1995). Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332:429-435.
19. Bryne M, Reibel J, Mandel U, Dabelsteen E (1991). Expression of mucin type carbohydrates may supplement histologic diagnosis in oral premalignant lesions. J Oral Pathol Med 20:120-125.
20. Bundgaard T, Sörensen FB, Gaihede M, Søgaard H, Overgaard J (1992). Stereologic, histopathologic, flow cytometric, and clinical parameters in the prognostic evaluation of 74 patients with intraoral squamous cell carcinomas. Cancer 70:1-13.
21. Burkhardt A, Maerker R (1978). Dysplasieklassifikation oraler leukoplakien und präkanzerosen. Bedeutung für prognose und therapie. Dtsch Z Mund-Kiefer-Gesichts-Chir 2:199-205.
22. Burkhardt A, Seifert G (1977). Morphologische klassifikation der oralen leukoplakien. Dtsch Med Wochenschr 102:223-229.
23. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. (1996). Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56:2488-2492.
24. Carey TE, Nair TS, Chern C, Liebert M, Grossman HB, Wolf GT, et al. (1993). Blood group antigens and integrins as biomarkers in head and neck cancer: is aberrant tyrosine phosphorylation the cause of altered alpha 6 beta 4 integrin expression? J Cell Biochem Suppl 17(F):223-232.
25. Cawson RA (1966). Chronic oral candidiasis and leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 22:582-591.
26. Cawson RA, Binnie WH (1980). Candida, leukoplakia and carcinoma: a possible relationship. In: Oral premalignancy. Proceedings of the First Dows Symposium. Mackenzie I, Dabelsteen E, Squier CA, editors. Iowa: University of Iowa Press, pp. 59-66.
27. Chang K-W, Lin S-C, Kwan P-C, Wong Y-K (2000). Association of aberrant p53 and p21WAF1 immunoreactivity with the outcome of oral verrucous leukoplakia in Taiwan. J Oral Pathol Med 29:56-62.
28. Chiesa F, Boracchi P, Tradati N, Rossi N, Costa L, Giardini R, et al. (1993). Risk of preneoplastic and neoplastic events in operated oral leukoplakias. Eur J Cancer B Oral Oncol 29(B):23-28.
29. Clausen H, Hakomori S (1989). ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang 56:1-20.
30. Cowan CG, Gregg TA, Napier SS, McKenna SM, Kee F (2001). Potentially malignant oral lesions in northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis 7:18-24.
31. Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM, et al. (1998). p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 184:360-368.
32. Cruz IB, Meijer CJ, Snijders PJ, Snow GB, Walboomers JM, van der Waal I (2000). p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management. J Pathol 191:132-137.
33. Dabelsteen E (2002). ABO blood group antigens in oral mucosa. What is new? J Oral Pathol Med 31:65-70.
34. Dabelsteen E, Fulling HJ (1971). A preliminary study of blood group substances A and B in oral epithelium exhibiting atypia. Scand J Dent Res 79:387-393.
35. Dabelsteen E, Pindborg JJ (1973). Loss of epithelial blood group substance A in oral carcinomas. Acta Pathol Microbiol Scand [A] 81:435-444.
36. Dabelsteen E, Roed-Petersen B, Pindborg JJ (1975). Loss of epithelial blood group antigens A and B in oral premalignant lesions. Acta Pathol Microbiol Immunol Scand [A] 83:292-300.
37. Dabelsteen E, Vedtofte P, Hakomori SI, Young WW (1982). Carbohydrate chains specific for blood group antigens in differentiation of human oral epithelium. J Invest Dermatol 79:3-7.
38. Dabelsteen E, Vedtofte P, Hakomori S, Young WW Jr (1983). Accumulation of a blood group antigen precursor in oral premalignant lesions. Cancer Res 43:1451-1454.
39. Dabelsteen E, Clausen H, Holmstrup P, Reibel J (1988). Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens. APMIS 96:813-819.
40. Dabelsteen E, Clausen H, Mandel U (1991a). Aberrant glycosylation in oral malignant and premalignant lesions. J Oral Pathol Med 20:361-368.
41. Dabelsteen E, Mandel U, Clausen H (1991b). Cell surface carbohydrates are markers of differentiation in human oral epithelium. Crit Rev Oral Biol Med 2:493-507.
42. Dabelsteen E, Grøn B, Mandel U, Mackenzie I (1998). Altered expression of epithelial cell surface glycoconjugates and intermediate filaments at the margins of mucosal wounds. J Invest Dermatol 111:592-597.
43. De Paula AM, Carvalhais JN, Domingues MG, Barreto DC, Mesquita RA (2000). Cell proliferation markers in the odontogenic keratocyst: effect of inflammation. J Oral Pathol Med 29:477-482.
44. de Vries N, van der Waal I, Snow GB (1986). Multiple primary tumours in oral cancer. Int J Oral Maxillofac Surg 15:85-87.
45. Dowell SP, Ogden GR (1996). The use of antigen retrieval for immunohistochemical detection of p53 over-expression in malignant and benign oral mucosa: a cautionary note. J Oral Pathol Med 25:60-64.
46. Downer MC, Evans AW, Hughes Hallet CM, Jullien JA, Speight PM, Zakrzewska JM (1995). Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dent Oral Epidemiol 23:84-88.
47. Eaden J, Abrams K, McKay H, Denley H, Mayberry J (2001). Interobserver variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol 194:152-157.
48. Ephros H, Samit A (1997). Leukoplakia and malignant transformation (comment/letter). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83:187.
49. Eversole LR, Shopper TP (1981). Oral leukoplakia: prevalence of dysplastic and carcinomatous change in verruciform and planar patterns. CA Dent Assoc J 9:45-51.
50. Gao S, Dabelsteen E, Reibel J, Bennett EP (2003). Genotypic characterization of histo-blood group ABO in oral squamous cell carcinomas (abstract). J Dent Res (in press).
51. Girod SC, Pfeiffer P, Ries J, Pape HD (1998). Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Br J Oral Maxillofac Surg 36:252-260.
52. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
53. Gundlach KKH (1992). Wieviele plattenepithelkarzinome der mundhöhle sind aus leukoplakien entstanden? Dtsch Z Mund-Kiefer-Gesichts-Chir 16:109-111.
54. Gupta PC, Mehta FS, Daftary DK, Pindborg JJ, Bhonsle RB, Jalnawalla PN, et al. (1980). Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year followup study of Indian villagers. Community Dent Oral Epidemiol 8:283-333.
55. Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Mehta FS, Pindborg JJ (1989). An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer 63:2247-2252.
56. Gupta PC, Murti PR, Bhonsle RB, Mehta FS, Pindborg JJ (1995). Effect of cessation of tobacco use on the incidence of oral mucosal lesions in a 10-yr follow-up study of 12,212 users. Oral Dis 1:54-58.
57. Hansen LS, Olson JA, Silverman SJ (1985). Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 60:285-298.
58. Heyden A, Huitfeldt HS, Koppang HS, Thrane PS, Bryne M, Brandtzaeg P (1992). Cytokeratins as epithelial differentiation markers in premalignant and malignant oral lesions. J Oral Pathol Med 21:7-11.
59. Högmo A, Munck-Wikland E, Kuylenstierna R, Lindholm J, Auer G (1996). Nuclear DNA content and p53 immunostaining in metachronous preneoplastic lesions and subsequent carcinomas of the oral cavity. Head Neck 18:433-440.
60. Holmstrup P, Bessermann M (1983). Clinical, therapeutic, and pathogenic aspects of chronic oral multifocal candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 56:388-395.
61. Hornstein OP, Grässel R (1992). Häufigkeit und prognostische bedeutung der candida-besiedelung oraler leukoplakien. Dtsch Z Mund-Kiefer-Gesichts-Chir 16:112-116.
62. Idris AM, Warnakulasuriya KAAS, Ibrahim IE, Nilsen R, Cooper D, Johnson NW (1996). Toombak-associated oral mucosal lesions in Sudanese show a low prevalence of epithelial dysplasia. J Oral Pathol Med 25:239-244.
63. Jepsen A, Winther JE (1965). Mycotic infection in oral leukoplakia. Acta Odontol Scand 23:239-256.
64. Jiang WW, Fujii H, Shirai T, Mega H, Takagi M (2001). Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity. Cancer 92:2349-2356.
65. Johnson NW, Ranasinghe AW, Warnakulasuriya KA (1993). Potentially malignant lesions and conditions of the mouth and oropharynx: natural history-cellular and molecular markers of risk. Eur J Cancer Prev 2(Suppl 2):31-51.
66. Kahn MA, Mincer HH, Dockter ME, Hermann-Petrin JM (1993). Comparing flow cytometric analysis and nucleolar organizer region enumeration in archival oral premalignant lesions. J Oral Pathol Med 22:257-262.
67. Kaplan I, Vered M, Moskona D, Buchner A, Dayan D (1998). An immunohistochemical study of p53 and PCNA in inflammatory papillary hyperplasia of the palate: a dilemma of interpretation. Oral Dis 4:194-199.
68. Karabulut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW, Dabelsteen E (1995). Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 24:198-200.
69. Katz HC, Shear M, Altini M (1985). A critical evaluation of epithelial dysplasia in oral mucosal lesions using the Smith-Pindborg method of standardization. J Oral Pathol 14:476-482.
70. Kaugars GE, Burns JC, Gunsolley JC (1988). Epithelial dysplasia of the oral cavity and lips. Cancer 62:2166-2170.
71. Kramer IR, Lucas RB, el-Labban N, Lister L (1970). The use of discriminant analysis for examining the histological feathers of oral keratoses and lichen planus. Br J Cancer 24:673-683.
72. Kramer IR, el-Labban N, Lee KW (1978). The clinical features and risk of malignant transformation in sublingual keratosis. Br Dent J 144:171-180.
73. Krogh P, Hald B, Holmstrup P (1987a). Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of Nnitrosobenzylmethylamine. Carcinogenesis 8:1543-1548.
74. Krogh P, Holmstrup P, Thorn JJ, Vedtofte P, Pindborg JJ (1987b). Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 63:48-54.
75. Krutchkoff DJ, Eisenberg E, Anderson C (1991). Dysplasia of oral mucosa: a unified approach to proper evaluation. Mod Pathol 4:113-119.
76. Kushner J, Bradley G, Jordan RC (1997). Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth. J Pathol 183:418-423.
77. Le Bars P, Piloquet P, Daniel A, Giumelli B (2001). Immunohistochemical localization of type IV collagen and laminin (alpha1) in denture stomatitis. J Oral Pathol Med 30:98-103.
78. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, et al. (2000). Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 6:1702-1710.
79. Lesch CA, Squier CA, Cruchley A, Williams DM, Speight P (1989). The permeability of human oral mucosa and skin to water. J Dent Res 68:1345-1349.
80. Lind PO (1987). Malignant transformation in oral leukoplakia. Scand J Dent Res 95:449-455.
81. Lindberg K, Rheinwald JG (1989). Suprabasal 40 kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium. Am J Pathol 134:89-98.
82. Lumerman H, Freedman P, Kerpel S (1995). Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79:321-329.
83. MacDonald DG, Rennie JS (1975). Oral epithelial atypia in denture induced hyperplasia, lichen planus and squamous cell papilloma. Int J Oral Surg 4:40-45.
84. Mandel U, Langkilde NC, Orntoft TF, Therkildsen MH, Karkov J, Reibel J, et al. (1992). Expression of histo-blood-group-A/Bgene-defined glycosyltransferases in normal and malignant epithelia: correlation with A/B-carbohydrate expression. Int J Cancer 52:7-12.
85. Mandel U, Hassan H, Therkildsen MH, Rygaard J, Jakobsen MH, Juhl BR, et al. (1999). Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family. Glycobiology 9:43-52.
86. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, et al. (1996). Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 2:682-685.
87. Mattson ME, Winn DM (1989). Smokeless tobacco: association with increased cancer risk. NCI Monogr 8:13-16.
88. McCartan B (1998). Malignant transformation of leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:348-349.
89. Meeting report (1997). Third European congress of oral medicine. Oral Dis 3:43-48.
90. Mehta FS, Pindborg JJ, Gupta PC, Daftary DK (1969). Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in India. Cancer 24:832-849.
91. Mehta FS, Schroff BC, Gupta PC, Daftary DK (1972). Oral leukoplakia in relation to tobacco habits. A ten-year follow-up study of Bombay policemen. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 34:426-433.
92. Mignogna MD, Fedele S, Ruoppo E, Russo LL (2002). Two sides of a prevention "coin": adequate screening and better tools (letter to the editor). J Oral Pathol Med 31:246-248.
93. Miller CS, Johnstone BM (2001). Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:622-635.
94. Mincer HH, Coleman SA, Hopkins KP (1972). Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 33:389-399.
95. Moll UM, Schramm LM (1998). p53-an acrobat in tumorigenesis. Crit Rev Oral Biol Med 9:23-37.
96. Morgan PR, Leigh IM, Purkis PE, Gardner ID, van Muijen GNP, Lane EB (1987). Site variation of keratin expression in human oral epithelia-an immunocytochemical study on individual keratins. Epithelia 1:31-43.
97. Murti PR, Warnakulasuriya KA, Johnson NW, Bhonsle RB, Gupta PC, Daftary DK, et al. (1998). p53 expression in oral precancer as a marker for malignant potential. J Oral Pathol Med 27:191-196.
98. Nielsen H, Norrild B, Vedtofte P, Praetorius F, Reibel J, Holmstrup P (1996). Human papillomavirus in oral premalignant lesions. Eur J Cancer B Oral Oncol 32(B):264-270.
99. Nylander K, Dabelsteen E, Hall PA (2000). The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 29:413-425.
100. O'Grady JF, Reade PC (1992). Candida albicans as a promoter of oral mucosal neoplasia. Carcinogenesis 13:783-786.
101. Ogden GR, Lane EB, Hopwood DV, Chisholm DM (1993). Evidence for field change in oral cancer based on cytokeratin expression. Br J Cancer 67:1324-1330.
102. Ogden GR, Chisholm DM, Morris AM, Stevenson JH (1997). Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease. J Pathol 182:180-184.
103. Orntoft TF (1990). Expression and biosynthesis of ABH-related carbohydrate antigens in normal and pathologic human urothelium. APMIS Suppl 17:1-34.
104. Park CC, Bissell MJ, Barcellos-Hoff MH (2000). The influence of the microenvironment on the malignant phenotype. Mol Med Today 6:324-329.
105. Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J (1997). Field cancerisation of the oral cavity: comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions. Oral Oncol 33:332-337.
106. Partridge M, Pateromichelakis S, Phillips E, Emilion GG, A'Hern RP, Langdon JD (2000). A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res 60:3893-3898.
107. Patel V, Leethanakul C, Gutkind JS (2001). New approaches to the understanding of the molecular basis of oral cancer. Crit Rev Oral Biol Med 12:55-63.
108. Paterson IC, Eveson JW, Prime SS (1996). Molecular changes in oral cancer may reflect aetiology and ethnic origin. Eur J Cancer B Oral Oncol 32(B):150-153.
109. Piffko J, Bankfalvi A, Öfner D, Berens A, Tkotz T, Joos U, et al. (1995). Expression of p53 protein in oral squamous cell carcinomas and adjacent non-tumorous mucosa of the floor of the mouth: an archival immunohistochemical study using wet autoclave pretreatment for antigen retrieval. J Oral Pathol Med 24:337-342.
110. Piffko J, Bankfalvi A, Joos U, Öfner D, Krassort M, Schmid KW (1999). Immunophenotypic analysis of normal mucosa and squamous cell carcinoma of the oral cavity. Cancer Detect Prev 23:45-56.
111. Pindborg JJ, Renstrup G, Poulsen HE, Silverman S (1963). Studies in oral leukoplakias. V. Clinical and histologic signs of malignancy. Acta Odontol Scand 21:407-414.
112. Pindborg JJ, Jolst O, Renstrup G, Roed-Petersen B (1968). Studies in oral leukoplakia: a preliminary report on the period prevalence of malignant transformation in leukoplakia based on a followup study of 248 patients. J Am Dent Assoc 76:767-771.
113. Pindborg JJ, Daftary DK, Mehta FS (1977). A follow-up study of sixty-one oral dysplastic precancerous lesions in Indian villagers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 43:383-390.
114. Pindborg JJ, Reibel J, Roed-Peterson B, Mehta FS (1980). Tobaccoinduced changes in oral leukoplakic epithelium. Cancer 45:2330-2336.
115. Pindborg JJ, Reibel J, Holmstrup P (1985). Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 14:698-708.
116. Pindborg JJ, Reichart P, Smith CJ, van der Waal I (1997). World Health Organization: histological typing of cancer and precancer of the oral mucosa. Berlin: Springer-Verlag.
117. Poh CF, Zhang L, Lam WL, Zhang X, An D, Chau C, et al. (2001). A high frequency of allelic loss in oral verrucous lesions may explain malignant risk. Lab Invest 81:629-634.
118. Praetorius F (1997). HPV-associated diseases of oral mucosa. Clin Dermatol 15:399-413.
119. Prime SS, Rosser TJ, Davies LS, Scully C (1987). Loss of epithelial cell surface carbohydrates during experimental oral carcinogenesis in the rat. Br J Cancer 55:633-638.
120. Pritlove-Carson S, Charlesworth S, Morgan PR, Palmer RM (1997). Cytokeratin phenotypes at the dento-gingival junction in relative health and inflammation, in smokers and nonsmokers. Oral Dis 3:19-24.
121. Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K (1995). Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 55:4132-4139.
122. Ranasinghe AG, Maceoch C, Dyer S, Spurr N, Johnson NW (1993). Some oral carcinomas from Sri Lankan betel/tobacco chewers overexpress p53 oncoprotein but lack mutations in head and neck cancer. Anticancer Res 13:2065-2068.
123. Ravn V, Dabelsteen E (2000). Tissue distribution of histo-blood group antigens. APMIS 108:1-28.
124. Regezi JA, Zarbo RJ, Regev E, Pisanty S, Silverman S, Gazit D (1995). p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas. J Oral Pathol Med 24:18-22.
125. Reibel J, Sorensen CH (1991). Association between keratin staining patterns and the structural and functional aspects of palatine tonsil epithelium. APMIS 99:905-915.
126. Reibel J, Clausen H, Dabelsteen E (1985). Staining patterns of human pre-malignant oral epithelium and squamous cell carcinomas by monoclonal anti-keratin antibodies. Acta Pathol Microbiol Immunol Scand [A] 93:323-330.
127. Reibel J, Wallenius K, Dabelsteen E (1988). Blood group antigen staining pattern during experimental carcinogenesis in rat palate. APMIS 96:161-167.
128. Renan MJ (1993). How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 7:139-146.
129. Renstrup G (1970). Occurrence of candida in oral leukoplakias. Acta Pathol Microbiol Scand [B] Microbiol Immunol 78:421-424.
130. Richart RM, Barron BA (1969). A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 105:386-393.
131. Ringsted J, Amtrup F, Asklund C, Baunsgaard P, Christensen HE, Hansen L, et al. (1978). Reliability of histo-pathological diagnosis of squamous epithelial changes of the uterine cervix. Acta Pathol Microbiol Scand [A] 86:273-278.
132. Roed-Petersen B (1982). Effect on oral leukoplakia of reducing or ceasing tobacco smoking. Acta Derm Venereol 62:164-167.
133. Roed-Petersen B, Renstrup G, Pindborg JJ (1970). Candida in oral leukoplakias. A histologic and exfoliative cytologic study. Scand J Dent Res 78:323-328.
134. Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, et al. (2000). Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 6:357-362.
135. Rowley H, Helliwell TR, Jones AS, Roland NJ, Field EA, Field JK (1997). An immunohistochemical analysis of p53 protein expression in pre-malignant and malignant tissues of the oral cavity. Clin Otolaryngol 22:23-29.
136. Russell C, Jones JH (1975). The histology of prolonged candidal infection of the rat's tongue. J Oral Pathol 4:330-339.
137. Saito T, Yamashita T, Notani K, Fukuda H, Mizuno S, Shindoh M, et al. (1995). Flow cytometric analysis of nuclear DNA content in oral leukoplakia: relation to clinicopathologic findings. Int J Oral Maxillofac Surg 24:44-47.
138. Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, et al. (1999). High malignant transformation rate of widespread multiple oral leukoplakias. Oral Dis 5:15-19.
139. Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, et al. (2001). Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg 30:49-53.
140. Scheifele C, Reichart PA (1998). Orale leukoplakien bei manifestem plattenepithelkarzinom. Mund Kiefer Gesichtschir 2:326-330.
141. Schepman KP, van der Waal I (1995). A proposal for a classification and staging system for oral leukoplakia: a preliminary study. Eur J Cancer B Oral Oncol 31(B):396-398.
142. Schepman KP, van der Meij EH, Smeele LE, van der Waal I (1998). Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 34:270-275.
143. Schepman K, van der Meij EH, Smeele L, van der Waal I (1999). Concomitant leukoplakia in patients with oral squamous cell carcinoma. Oral Dis 5:206-209.
144. Schepman KP, Bezemer PD, van der Meij EH, Smeele LE, van der Waal I (2001). Tobacco usage in relation to the anatomical site of oral leukoplakia. Oral Dis 7:25-27.
145. Schimming R, Hlawitschka M, Haroske G, Eckelt U (1998). Prognostic relevance of DNA image cytometry in oral cavity carcinomas. Anal Quant Cytol Histol 20:43-51.
146. Schoelch ML, Sekandari N, Regezi JA, Silverman SJ (1999a). Laser management of oral leukoplakias: a follow-up study of 70 patients. Laryngoscope 109:949-953.
147. Schoelch ML, Le QT, Silverman S Jr, McMillan A, Dekker NP, Fu KK, et al. (1999b). Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Oral Oncol 35:77-85.
148. Schoelch ML, Regezi JA, Dekker NP, Ng IO, McMillan A, Ziober BL, et al. (1999c). Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol 35:333-342.
149. Schwartz JL (2000). Biomarkers and molecular epidemiology and chemoprevention of oral carcinogenesis. Crit Rev Oral Biol Med 11:92-122.
150. Scully C, Burkhardt A (1993). Tissue markers of potentially malignant human oral epithelial lesions. J Oral Pathol Med 22:246-256.
151. Scully C, Field JK (1997). Genetic aberrations in squamous cell carcinoma of the head and neck with reference to oral carcinoma. Int J Oncol 10:5-21.
152. Shafer WG, Waldron CA (1961). A clinical and histopathologic study of oral leukoplakia. Surg Gynecol Obstet 112:411-420.
153. Shafer WG, Waldron CA (1975). Erythroplakia of the oral cavity. Cancer 36:1021-1028.
154. Shahnavaz SA, Regezi JA, Bradley G, Dube ID, Jordan RC (2000). p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas. J Pathol 190:417-422.
155. Silverman S Jr, Gorsky M (1997). Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:154-157.
156. Silverman S, Rosen RD (1968). Observations of the clinical characteristics and natural history of oral leukoplakia. J Am Dent Assoc 76:772-777.
157. Silverman S, Bhargava K, Smith LW, Malaowalla AM. (1976). Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat, India. Cancer 38:1790-1795.
158. Silverman S Jr, Gorsky M, Lozada F (1984). Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 53:563-568.
159. Silverman S Jr, Gorsky M, Kaugars GE (1996). Leukoplakia, dysplasia, and malignant transformation (editorial). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82:117.
160. Slootweg PJ, Koole R, Hordijk GJ (1994). The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Eur J Cancer B Oral Oncol 30(B):138-141.
161. Smith CJ, Pindborg JJ (1969). Histological grading of oral epithelial atypia by the use of photographic standards. Copenhagen: C. Hamburgers Bogtrykkeri.
162. Speight P, Farthing PM, Bouquot JE (1996). The pathology of oral cancer and precancer. Curr Diagn Pathol 3:165-177.
163. Steinbeck RG, Moege J, Heselmeyer KM, Klebe W, Neugebauer W, Borg B, et al. (1993). DNA content and PCNA immunoreactivity in oral precancerous and cancerous lesions. Eur J Cancer B Oral Oncol 29(B):279-284.
164. Su L, Morgan PR, Lane EB (1994). Protein and mRNA expression of simple epithelial keratins in normal, dysplastic, and malignant oral epithelia. Am J Pathol 145:1349-1357.
165. Su L, Morgan PR, Lane EB (1996). Keratin 14 and 19 expression in normal, dysplastic and malignant oral epithelia. A study using in situ hybridization and immunohistochemistry. J Oral Pathol Med 25:293-301.
166. Sudbø J, Bryne M, Johannessen AC, Kildal W, Danielsen HE, Reith A (2001a). Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia. J Pathol 194:303-310.
167. Sudbø J, Ried T, Bryne M, Kildal W, Danielsen H, Reith A (2001b). Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches. Oral Oncol 37:558-565.
168. Sudbø J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A (2001c). DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 344:1270-1278.
169. Sudbø J, Kildal W, Johannessen AC, Koppang HS, Sudbø A, Danielsen HE, et al. (2002). Gross genomic aberrations in precancers: clinical implications of a long-term follow-up study in oral erythroplakias. J Clin Oncol 20:456-462.
170. Thorup AK, Reibel J, Schiødt M, Stenersen TC, Therkildsen MH, Carter WG, et al. (1998). Can alterations in integrin and laminin-5 expression be used as markers of malignancy? APMIS 106:1170-1180.
171. Thykjaer T, Workman C, Kruhoffer M, Demtroder K, Wolf H, Andersen LD, et al. (2001). Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res 61:2492-2499.
172. To AC, Soong SJ, Shingleton HM, Gore H, Wilkerson JA, Hatch KD, et al. (1986). Immunohistochemistry of the blood group A,B,H isoantigens and Oxford Ca antigen as prognostic markers for stage IB squamous cell carcinoma of the cervix. Cancer 58:2435-2439.
173. Tosios KI, Kapranos N, Papanicolaou SI (1998). Loss of basement membrane components laminin and type IV collagen parallels the progression of oral epithelial neoplasia. Histopathology 33:261-268.
174. van der Toorn PP, Veltman JA, Bot FJ, de Jong JM, Manni JJ, Ramaekers FC, et al. (2001). Mapping of resection margins of oral cancer for p53 overexpression and chromosome instability to detect residual (pre)malignant cells. J Pathol 193:66-72.
175. van der Waal I, Schepman KP, van der Meij EH, Smeele LE (1997). Oral leukoplakia: a clinicopathological review. Oral Oncol 33:291-301.
176. van der Waal I, Schepman KP, van der Meij EH (2000). A modified classification and staging system for oral leukoplakia. Oral Oncol 36:264-266.
177. van Oijen MG, Tilanus MG, Medema RH, Slootweg PJ (1998). Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med 27:367-375.
178. Vedtofte P, Holmstrup P, Hjørting-Hansen E, Pindborg JJ (1987). Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg 16:656-664.
179. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, et al. (2002). Colorectal cancer in mice genetically deficient in the mucin muc2. Science 295:1726-1729.
180. Vigneswaran N, Peters KP, Hornstein OP, Haneke E (1989). Comparison of cytokeratin, filaggrin and involucrin profiles in oral leukoplakias and squamous carcinomas. J Oral Pathol Med 18:377-390.
181. Waldron CA, Shafer WG (1975). Leukoplakia revisited. A clinicopathologic study of 3256 oral leukoplakias. Cancer 36:1386-1392.
182. Warnakulasuriya S (1998). p53 and oral precancer-a review. In: Oral oncology. Varma AK, editor. New Delhi: McMillan, pp. 93-96.
183. Warnakulasuriya S (2000). Lack of molecular markers to predict malignant potential of oral precancer. J Pathol 190:407-409.
184. Warnakulasuriya S (2001). Histological grading of oral epithelial dysplasia: revisited. J Pathol 194:294-297.
185. Warnakulasuriya S (2002). Cancers of the oral cavity and pharynx. In: Genetic basis of human cancer. Vogelstein B, Kinzler KW, editors. London: McGraw-Hill, pp. 773-784.
186. Warnakulasuriya KA, Johnson NW (1992). Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 21:404-408.
187. Warnakulasuriya KA, Johnson NW (1996). Importance of proliferation markers in oral pathology. Curr Top Pathol 90:147-177.
188. Warnakulasuriya KAAS, Tavassoli M, Johnson NW (1998). Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma. J Oral Pathol Med 27:376-381.
189. Weijers M, Snow GB, Bezemer PD, van der Waal JE, van der Waal I (2002). The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma: an analysis of 37 patients. J Oral Pathol Med 31:11-15.
190. WHO (1978). Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 46:518-539.
191. Winn DM, Blot WJ (1985). Second cancer following cancers of the buccal cavity and pharynx in Connecticut, 1935-1982. Natl Cancer Inst Monogr 68:25-48.
192. Wright A, Shear M (1985). Epithelial dysplasia immediately adjacent to oral squamous cell carcinomas. J Oral Pathol 14:559-564.
193. Zain RB, Ikeda N, Gupta PC, Warnakulasuriya KAAS, van Wyk CW, Shrestha P, et al. (1999). Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: consensus from a workshop held in Kuala Lumpur, Malaysia, November 25-27, 1996. J Oral Pathol Med 28:1-4.
194. Zakrzewska JM, Lopes V, Speight P, Hopper C (1996). Proliferative verrucous leukoplakia: a report of ten cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82:396-401.
195. Zhang L, Rosin MP (2001). Loss of heterozygosity: a potential tool in management of oral premalignant lesions? J Oral Pathol Med 30:513-520.
196. Zhang L, Rosin MP (2002). Two sides of a prevention "coin": adequate screening and better tools (reply). J Oral Pathol Med 249-251.
197. Zhang L, Cheung KJ Jr, Lam WL, Cheng X, Poh C, Priddy R, et al. (2001). Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer 91:2148-2155.
198. Zhang X, Schmitz W, Gelderblom HR, Reichart P (2001). Shammahinduced oral leukoplakia-like lesions. Oral Oncol 37:609-612.